CU23879B1 - - Google Patents
Info
- Publication number
- CU23879B1 CU23879B1 CU20090172A CU20090172A CU23879B1 CU 23879 B1 CU23879 B1 CU 23879B1 CU 20090172 A CU20090172 A CU 20090172A CU 20090172 A CU20090172 A CU 20090172A CU 23879 B1 CU23879 B1 CU 23879B1
- Authority
- CU
- Cuba
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20090172A CU20090172A6 (es) | 2009-10-09 | 2009-10-09 | Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular |
| CN2010800556597A CN102656171A (zh) | 2009-10-09 | 2010-10-08 | 对血管系统和中枢神经系统起作用的三环和四环系统 |
| PCT/CU2010/000004 WO2011041989A2 (es) | 2009-10-09 | 2010-10-08 | Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular |
| KR1020127011917A KR20120093940A (ko) | 2009-10-09 | 2010-10-08 | 중추신경계 및 혈관계에 대한 활성을 갖는 트리시클릭 및 테트라시클릭 시스템 |
| EP10821598.9A EP2487174A4 (en) | 2009-10-09 | 2010-10-08 | TRICYCLIC AND TETRACYCLIC SYSTEMS WITH EFFECT ON THE CENTRAL NERVOUS AND VACUUM SYSTEM |
| US13/500,983 US9315497B2 (en) | 2009-10-09 | 2010-10-08 | Tricyclic and tetracyclic systems with activity on the central nervous and vascular systems |
| CA2777209A CA2777209C (en) | 2009-10-09 | 2010-10-08 | Tricyclic and tetracyclic systems with activity on the central-nervous and vascular systems |
| JP2012532450A JP2013507329A (ja) | 2009-10-09 | 2010-10-08 | 脈管系および中枢神経系に作用する三環系化合物および四環系化合物 |
| ZA2012/03295A ZA201203295B (en) | 2009-10-09 | 2012-05-07 | Tricyclic and tetracyclic systems with activity on the central-nervous and vascular systems |
| US14/282,111 US10138231B2 (en) | 2009-10-09 | 2014-05-20 | Tricyclic and tetracyclic systems acting upon the vascular and central nervous systems |
| US16/171,046 US20190092769A1 (en) | 2009-10-09 | 2018-10-25 | Tricyclic and tetracyclic systems acting upon the vascular and central nervous systems |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20090172A CU20090172A6 (es) | 2009-10-09 | 2009-10-09 | Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| CU20090172A7 CU20090172A7 (es) | 2011-10-05 |
| CU20090172A6 CU20090172A6 (es) | 2011-10-05 |
| CU23879B1 true CU23879B1 (es) | 2013-04-19 |
Family
ID=45000047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20090172A CU20090172A6 (es) | 2009-10-09 | 2009-10-09 | Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US9315497B2 (es) |
| EP (1) | EP2487174A4 (es) |
| JP (1) | JP2013507329A (es) |
| KR (1) | KR20120093940A (es) |
| CN (1) | CN102656171A (es) |
| CA (1) | CA2777209C (es) |
| CU (1) | CU20090172A6 (es) |
| WO (1) | WO2011041989A2 (es) |
| ZA (1) | ZA201203295B (es) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017190713A1 (es) * | 2016-05-04 | 2017-11-09 | Universidad De La Habana | Derivado de benzodiazepina con actividad sobre el sistema nervioso central y vascular |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201215033D0 (en) | 2012-08-23 | 2012-10-10 | Novartis Ag | Diazepinone derivatives |
| GB201510010D0 (en) | 2015-06-09 | 2015-07-22 | King S College London | PDD and BPD compounds |
| GB201514928D0 (en) | 2015-08-21 | 2015-10-07 | King S College London | PDD compounds |
| US20180339985A1 (en) | 2015-08-21 | 2018-11-29 | Femtogenix Limited | Pdd compounds |
| CU20190114A7 (es) | 2019-12-26 | 2021-08-06 | Centro De Investig Y Desarrollo De Medicamentos Cidem | Combinación para simultáneamente incrementar la eficacia analgésica de la morfina y reducir su dependencia física |
| KR20230066328A (ko) * | 2020-09-09 | 2023-05-15 | (주)스파크바이오파마 | 신규 피리미도디아제핀 유도체 및 이의 용도 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3780047A (en) | 1972-07-05 | 1973-12-18 | Squibb & Sons Inc | Derivatives of pyrazolo(3',4'-2,3)pyrido(4,5-e)b-benzo-1,5-diazepines |
| US4012373A (en) | 1972-09-22 | 1977-03-15 | E. R. Squibb & Sons, Inc. | Pyrazolo[3',4'-2,3]pyrido[4,5-e]b-benzo-1,5-diazepinones |
| US4970207A (en) | 1988-07-07 | 1990-11-13 | Fujisawa Pharmaceutical Company, Ltd. | Benzodiazepine derivatives |
| US5571809A (en) | 1989-04-20 | 1996-11-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | The treatment of HIV-1 infection using certain pyridodiazepines |
| EP0491218A1 (en) | 1990-12-17 | 1992-06-24 | F. Hoffmann-La Roche Ag | Benzodiazepinones |
| ATE143018T1 (de) | 1991-02-07 | 1996-10-15 | Boehringer Ingelheim Pharma | Pyridobenzodiazepine, dipyrido-(3,2-b:2',3'-3> (1,4>-diazepine und deren verwendung in der vorbeugung und behandlung von aids |
| EP0558104B1 (en) | 1992-01-21 | 1998-07-29 | GLAXO WELLCOME S.p.A. | 1,5-Benzodiazepine derivatives and their use in medicine |
| GB9201180D0 (en) | 1992-01-21 | 1992-03-11 | Glaxo Group Ltd | Chemical compounds |
| EP0625982B1 (en) | 1992-02-13 | 2002-06-12 | PHARMACIA & UPJOHN COMPANY | 4-oxo- and 4h-imidazo(5,1-c)(1,4)benzoxazines useful as benzodiazepine receptor-binding agents |
| AU692300B2 (en) | 1993-11-22 | 1998-06-04 | Merck & Co., Inc. | 2,3-dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1h-1, 4-benzodiazepines |
| ATE212994T1 (de) | 1994-08-31 | 2002-02-15 | Lilly Co Eli | Dihydro-2,3-benzodiazepinderivate |
| EG24221A (en) | 1995-03-24 | 2008-11-10 | Lilly Co Eli | Process for preparing olanzapine |
| TWI239333B (en) | 2000-11-16 | 2005-09-11 | Hoffmann La Roche | Benzodiazepine derivatives as GABA A receptor modulators |
| JP2006510634A (ja) * | 2002-12-03 | 2006-03-30 | ヴェラ ファーマスーティカルズ インコーポレイテッド | １−（３，４−ジメトキシフェニル）−４−メチル−５−エチル−７−メトキシ−８−ヒドロキシ−５ｈ−２，３−ベンゾジアゼピンの製薬組成物及びその用途 |
-
2009
- 2009-10-09 CU CU20090172A patent/CU20090172A6/es active IP Right Grant
-
2010
- 2010-10-08 CN CN2010800556597A patent/CN102656171A/zh active Pending
- 2010-10-08 CA CA2777209A patent/CA2777209C/en active Active
- 2010-10-08 WO PCT/CU2010/000004 patent/WO2011041989A2/es active Application Filing
- 2010-10-08 JP JP2012532450A patent/JP2013507329A/ja active Pending
- 2010-10-08 KR KR1020127011917A patent/KR20120093940A/ko not_active Application Discontinuation
- 2010-10-08 US US13/500,983 patent/US9315497B2/en not_active Expired - Fee Related
- 2010-10-08 EP EP10821598.9A patent/EP2487174A4/en not_active Withdrawn
-
2012
- 2012-05-07 ZA ZA2012/03295A patent/ZA201203295B/en unknown
-
2014
- 2014-05-20 US US14/282,111 patent/US10138231B2/en active Active
-
2018
- 2018-10-25 US US16/171,046 patent/US20190092769A1/en not_active Abandoned
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017190713A1 (es) * | 2016-05-04 | 2017-11-09 | Universidad De La Habana | Derivado de benzodiazepina con actividad sobre el sistema nervioso central y vascular |
| CN110114356A (zh) * | 2016-05-04 | 2019-08-09 | 哈瓦那大学 | 具有对中枢神经系统和血管系统的活性的苯并二氮卓衍生物 |
Also Published As
| Publication number | Publication date |
|---|---|
| CU20090172A7 (es) | 2011-10-05 |
| CU20090172A6 (es) | 2011-10-05 |
| EP2487174A2 (en) | 2012-08-15 |
| ZA201203295B (en) | 2014-10-29 |
| WO2011041989A2 (es) | 2011-04-14 |
| US10138231B2 (en) | 2018-11-27 |
| WO2011041989A3 (es) | 2011-09-15 |
| KR20120093940A (ko) | 2012-08-23 |
| JP2013507329A (ja) | 2013-03-04 |
| US9315497B2 (en) | 2016-04-19 |
| CA2777209C (en) | 2016-11-22 |
| US20140275042A1 (en) | 2014-09-18 |
| CA2777209A1 (en) | 2011-04-14 |
| EP2487174A4 (en) | 2013-05-08 |
| US20190092769A1 (en) | 2019-03-28 |
| CN102656171A (zh) | 2012-09-05 |
| US20120202791A1 (en) | 2012-08-09 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant of patent |